AdipoGenix
Boston
About AdipoGenix
AdipoGenix a biopharmaceutical company, develops pharmaceuticals that target human fat tissue to treat obesity and its co-morbidities, including diabetes and cardiovascular disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2005)
- Website: adipogenix.com
- Phone: 617-638-6394
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/adipogenix-1652535 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.